Role of stimulatory guanine nucleotide binding protein (G(Sα)) in proliferation of PC-3M prostate cancer cells

International Journal of Cancer

Volumn 91, Issue 1, 2001, Pages 46-54

  Chien, Jeremy ^a,c   Shah, Girish V ^a,b,c  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^c TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

G protein cell proliferation; Prostate cancer

Indexed keywords

8 BROMO CYCLIC AMP; ADENYLATE CYCLASE; ANDROGEN; CALCITONIN; COMPLEMENTARY DNA; FORSKOLIN; GUANINE NUCLEOTIDE BINDING PROTEIN; NIFEDIPINE; PROTEIN KINASE C;

ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INVASION; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE CANCER;

8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ADENYLATE CYCLASE; BLOTTING, WESTERN; CALCITONIN; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; CELL DIVISION; CYCLIC AMP; DNA REPLICATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FORSKOLIN; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; GTP-BINDING PROTEINS; HUMANS; MALE; NIFEDIPINE; PROSTATIC NEOPLASMS; PROTEIN KINASE C; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED; VERAPAMIL;

EID: 0035195434     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20010101)91:1<46::AID-IJC1008>3.0.CO;2-0     Document Type: Article

References (46)

1. Results of radical prostatectomy in men with clinically localized prostate cancer
2. Hormone therapy of prostatic bone metastases
3. Neuroendocrine cells in the normal, hyperplastic and neoplastic prostate
4. BCL-2 proto-oncogene expression in prostate cancer and its relationship to the prostatic neuroendocrine cell
5. Neuroendocrine cells in the human prostate gland
6. Characterization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinoma
7. Neuroendocrine differentiation in carcinoma of the prostate. Diagnostic, prognostic, and therapeutic implications
8. Presence of calcitonin-like immunoreactivity in human prostate gland evidence for iCT secretion by cultured prostate cells
9. Calcitonin stimulates growth of human prostate cells through receptor-mediated increase in cyclic adenosine 3',5'-monophosphates and cytoplasmic Ca2+ transients
10. Effects of the calciotrophic peptides calcitonin and parathyroid hormone on prostate cancer growth and chemotaxis
11. Growth inhibition of human prostatic carcinoma cell lines by serotonin antagonists
12. Differential effects of peptide hormones bombesin, vasoactive intestinal polypeptide and somatostatin analog RC-160 on the invasive capacity of human prostatic carcinoma cells
13. Muscarinic cholinergic receptors promote growth of human prostate cancer cells
14. Metastatic behavior of human tumor cell lines grown in the nude mouse
15. Characterization of a human prostate adenocarcinoma cell line (DU 145) as a monolayer culture and as a solid tumor in athymic mice
16. LNCaP model of human prostatic carcinoma
17. Determination of adenylyl cyclase catalytic activity using single and double column procedures
18. Mutated alpha subunit of the Gq protein induces malignant transformation in NIH 3T3 cells
19. Suppression of Ras-induced transformation of NIH 3T3 cells by activated G alpha s
20. Regulation of apoptosis and cell cycle arrest by Zacl, a novel zinc finger protein expressed in the pituitary gland and the brain
21. Thyroid hormone regulation of transmembrane signalling in neonatal rat ventricular myocytes by selective alteration of the expression and coupling of G-protein alpha-subunits
22. Characterization of mammalian Gs-alpha proteins expressed in yeast
23. Genomic effects of the putative oncogene G alpha s. Chronic transcriptional activation of the c-fos proto-oncogene in endocrine cells
24. Expression of mutationally activated G alpha s stimulates growth and differentiation of thyroid FRTL5 cells
25. Terminal neuroendocrine differentiation of human prostate carcinoma cells in response to increased intracellular cyclic AMP
26. Growth responses of normal, benign hyperplastic, and malignant human prostatic epithelial cells in vitro to cholera toxin, pituitary extract, and hydrocortisone
27. Distribution of Gs-alpha activating mutations in human thyroid tumors measured by subcloning
28. The inhibition of the paracrine progression of prostate cancer as an approach to early therapy of prostatic carcinoma
29. Two different pituitary adenomas in a patient with multiple endocrine neoplasia type 1 associated with growth hormone-releasing hormone-producing pancreatic tumor: Clinical and genetic features
30. Gs alpha: Identification of a gene highly expressed by insulinoma and other endocrine tumors
31. Identification of G protein alpha subunit mutations in human growth hormone (GH)- and GH/prolactin-secreting pituitary tumors by single-strand conformation polymorphism (SSCP) analysis
32. Pituitary adenylate cyclase-activating polypeptide (PACAP) stimulates adenylate cyclase and promotes proliferation of mouse primordial germ cells
33. Regulation of Lewis lung carcinoma invasion and metastasis by protein kinase A
34. A Gs protein couples P2-purinergic stimulation to cardiac Ca channels without cyclic AMP production
35. 2+ channel of skeletal muscle
36. Requirement of phosphatidylinositol-3 kinase for activation of JNK/SAPKs by PDGF
37. Calcium-cell cycle regulator, differentiator, killer, chemopreventor, and maybe, tumor promoter
38. Calcium/calmodulin regulation of the rat prolactin gene is conferred by the proximal enhancer region
39. Functional and morphological characterization of four cell lines derived from GH3 cells stably transfected with gonadotropin-releasing hormone receptor complementary deoxyribonucleic acid
40. 2+))-dependent mechanisms in cell homogenates from rabbit skeletal muscle
41. 2+ channel antagonists
42. Effects of calcium channel blockers on NIH 3T3 fibroblasts expressing the Ha-ras oncogene
43. Signal transduction pathways in the mitogenic response to G protein-coupled neuropeptide receptor agonists
44. Neurotransmitters as growth regulatory signals: Role of receptors and second messengers
45. Elevated plasma chromogranin-A concentrations in prostatic carcinoma
46. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate